Pramipexole Extended Release: A Novel Treatment Option in Parkinson's Disease

Pramipexole Extended Release: A Novel Treatment Option in Parkinson's Disease

Pramipexole, the most commonly prescribed dopamine agonist worldwide, meanwhile serves as a reference substance for evaluation of new drugs. Based on numerous clinical data and vast experiences, efficacy and safety profiles of this non-ergoline dopamine agonist are well characterized. Since October...

Full description

Saved in:

Bibliographic Details
Main Authors:	Wolfram Eisenreich, Bernd Sommer, Sebastian Hartter, Wolfgang H. Jost
Format:	Article
Language:	English
Published:	Wiley 2010-01-01
Series:	Parkinson's Disease
Online Access:	http://dx.doi.org/10.4061/2010/612619
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Efficacy and Safety of Pramipexole Sustained Release versus Immediate Release Formulation for Nocturnal Symptoms in Chinese Patients with Advanced Parkinson’s Disease: A Pilot Study
by: Haiyan Zhou, et al.
Published: (2021-01-01)

Transfection of the BDNF Gene in the Surviving Dopamine Neurons in Conjunction with Continuous Administration of Pramipexole Restores Normal Motor Behavior in a Bilateral Rat Model of Parkinson’s Disease
by: Alina Benítez-Castañeda, et al.
Published: (2024-01-01)

The Efficacy of Pramipexole, a Dopamine Receptor Agonist, as an Adjunctive Treatment in Treatment-Resistant Depression: An Open-Label Trial
by: Hiroaki Hori, et al.
Published: (2012-01-01)

Dosing Patterns during Conversion to IPX066, Extended-Release Carbidopa-Levodopa (ER CD-LD), in Parkinson’s Disease with Motor Fluctuations
by: John C. Morgan, et al.
Published: (2018-01-01)

Structure Identification and Risk Assurance of Unknown Impurities in Pramipexole Oral Drug Formulation
by: Raymond R. Tjandrawinata, et al.
Published: (2024-01-01)

A Novel Drive Option for Piezoelectric Ultrasonic Transducers
by: Diana Engelke, et al.
Published: (2011-01-01)

Stem Cell-Released Microvesicles and Exosomes as Novel Biomarkers and Treatments of Diseases
by: Yanfang Chen, et al.
Published: (2016-01-01)

Subcutaneous Extended-Release Buprenorphine Use in Pregnancy
by: Craig V. Towers, et al.
Published: (2020-01-01)

Successful Treatment with Clonazepam and Pramipexole of a Patient with Sleep-Related Eating Disorder Associated with Restless Legs Syndrome: A Case Report
by: Nobuyuki Kobayashi, et al.
Published: (2012-01-01)

Treatment of Advanced Parkinson's Disease
by: Sara Varanese, et al.
Published: (2010-01-01)

Degraded Impairment of Emotion Recognition in Parkinson’s Disease Extends from Negative to Positive Emotions
by: Chia-Yao Lin, et al.
Published: (2016-01-01)

Impact of Oxycodone HCl Extended-release Formulary Restrictions on Extended-release Opioid Market Share, Healthcare Resource Utilization and Costs in Commercial and Medicare Plans
by: Rolin L. Wade, et al.
Published: (2017-07-01)

Modern options of prokinetics in gastroesophageal reflux disease treatment
by: A. A. Sheptulin, et al.
Published: (2018-08-01)

Ropinirole and Pramipexole Promote Structural Plasticity in Human iPSC-Derived Dopaminergic Neurons via BDNF and mTOR Signaling
by: Ginetta Collo, et al.
Published: (2018-01-01)

Options of dyslipidemia treatment at non-alcoholic fatty liver disease
by: M. V. Mayevskaya, et al.
Published: (2018-08-01)

Disorders of esophageal clearance in gastroesophageal reflux disease and option of their treatment
by: O. A. Storonova, et al.
Published: (2012-04-01)

Increase in treatment compliance reveals new options of treatment of gastroesophageal reflux disease
by: Yu. V. Yevsyutina, et al.
Published: (2015-05-01)

Advances in hydrogel for diagnosis and treatment for Parkinson’s disease
by: Peining Zhu, et al.
Published: (2025-02-01)

Cognition Deficits in Parkinson’s Disease: Mechanisms and Treatment
by: Congcong Fang, et al.
Published: (2020-01-01)

Opicapone, a Novel Catechol-O-methyl Transferase Inhibitor, for Treatment of Parkinson's Disease "Off" Episodes
by: Amnon A. Berger, et al.
Published: (2022-06-01)

Case report: Local anesthesia with lidocaine infiltration for extended-release buprenorphine therapy
by: Pouya Azar, et al.
Published: (2025-01-01)

Targeting Histone Deacetylases: A Novel Approach in Parkinson’s Disease
by: Sorabh Sharma, et al.
Published: (2015-01-01)

Nanosensor-based imaging of realtime dopamine release in neurons derived from iPSCs of patients with Parkinson's disease
by: Nayeon Lee, et al.
Published: (2025-04-01)

Options of improvement of efficacy of gastroesophageal reflux disease treatment by dioctaedric smectite
by: O. A. Storonova, et al.
Published: (2015-10-01)

Modern options and prospects of treatment of resistant forms of gastroesophageal reflux disease
by: A. A. Sheptulin
Published: (2010-12-01)

Current Treatment Options for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
by: Melanie D Beaton
Published: (2012-01-01)

Zinc Monotherapy as an Alternative Treatment Option for Decompensated Liver Disease due to Wilson Disease?
by: Hansa Haftu, et al.
Published: (2020-01-01)

Pimavanserin Treatment for Parkinson’s Disease Psychosis in Clinical Practice
by: Khashayar Dashtipour, et al.
Published: (2021-01-01)

Use of Acupuncture in the Rehabilitation Treatment of Patients with Parkinson's Disease
by: Julio López Argüelles, et al.
Published: (2023-04-01)

Parkinson’s disease and exosomes: from pathogenesis to diagnosis and treatment
by: A. Mišeikaitė, et al.
Published: (2021-06-01)

Towards a Better Knowledge of Natural Methane Releases in the French Alps: A Field Approach
by: Frédérick Gal, et al.
Published: (2019-01-01)

Diagnostic and Treatment Options to the Patients Presenting with Neurological Symptoms Caused by Celiac Disease
by: Domantas Jakubauskas, et al.
Published: (2024-03-01)

Electroconvulsive treatment of a patient with Parkinson’s disease and moderate depression
by: John Erik Berg
Published: (2011-02-01)

Nutrients Release from a Novel Gel-Based Slow/Controlled Release Fertilizer
by: H. Ding, et al.
Published: (2016-01-01)

Drosophila Models of Parkinson's Disease: Discovering Relevant Pathways and Novel Therapeutic Strategies
by: Verónica Muñoz-Soriano, et al.
Published: (2011-01-01)

Pain at chronic pancreatitis: origin and treatment options
by: V. T. Ivashkin, et al.
Published: (2015-07-01)

Clinical Characteristics and Treatment Options of Peripheral Spondyloarthritis
by: ZENG Lulu, et al.
Published: (2024-12-01)

Current and Emerging Pharmacological Treatment Options for Dementia
by: John M. Ringman, et al.
Published: (2006-01-01)

Treatment options for Leber hereditary optic neuropathy
by: I. Povilaitytė, et al.
Published: (2018-12-01)

New treatment options for generalized myasthenia gravis
by: Antanas Vaitkus, et al.
Published: (2024-02-01)